central lymph node metastasis in patients with suspicious thyroid nodules

Predictors of occult central lymph node metastasis in patients with Bethesda V thyroid nodules

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202604584570832

Enrollment

100

Registered

2026-04-28

Start date

2025-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Central neck dissection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Bethesda V thyroid nodules on ultrasound-guided fine needle aspiration cytology (FNAC)

Exclusion criteria

Exclusion criteria: Proven metastatic lateral lymph nodes clinically or radiologically Distant metastasis Concurrent Parathyroidectomy

Design outcomes

Primary

Measure	Time frame
Central Lymph node involvement by metastatic cells	—

Secondary

Measure	Time frame
local recurrence of Thyroid malignancy	—

Countries

Egypt

Contacts

Public ContactMaha Ghanem

Ethics Committee member Patients Representative

ethics.committe@alexmed.edu.eg+201287740750

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 10, 2026